At the current stage of knowledge and in the absence of larger prospective studies, we are inclined to recommend screening older donors (>50 years) for the presence of CHIP to minimize the risk of DCL, an uncommon, yet frequently lethal, sequela of alloHSCT.
Feb 25, 2020
In the following article, we propose recommendations for donor work-up, taking into consideration the age of the donors.
Aug 30, 2004 · Potentially transmittable diseases from donors include infections, congenital disorders, and acquired illnesses like autoimmune diseases or malignancies.
In the following article, we propose recommendations for donor work-up, taking into consideration the age of the donors. In contrast to blood transfusions, stem ...
Recommendations for donor work-up are proposed, taking into consideration the age of the donors, to insure high standard quality in relation to the ...
Transmission of donor illness by stem cell transplantation: should screening be different in older donors? ... Hypothesis: can transfer of primary neoplasm ...
People also ask
How long after a stem cell transplant are you immunocompromised?
How long do you stay in isolation after a stem cell transplant?
What cancers are common after stem cell transplant?
What is the single most important factor to consider in donor selection for an allogeneic transplant?
Transmission of donor illness by stem cell transplantation: should screening be different in older donors? Bone Marrow Transplant. 2004; 34:657-665. Crossref.
D Niederwieser et al. Transmission of donor illness by stem cell transplantation: should screening be different in older donors? Bone Marrow Transplant.
Transmission of donor illness by stem cell transplantation: should screening be different in older donors? Bone Marrow Transplant. 2004; 34:657-665. Crossref.
Transmission of donor illness by stem cell transplantation: should screening be different in older donors? D Niederwieser; C Gentilini; A Gratwohl.